{'fraction_non_alphanumeric': 0.030729833546734954, 'fraction_numerical': 0.011523687580025609, 'mean_word_length': 5.855263157894737, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Synthesis, spectral and pharmacological studies on lanthanide(III) complexes of 3,5-pyrazoledicarboxylic acid

Complexes of cerium(III), lanthanum(III) and neodymium(III) with 3,5-pyrazoledicarboxylic acid (H3pdc) were synthesized and their compositions determined by elemental analysis. To identify the binding of Ce(III), La(III) and Nd(III) with H3pdc, detailed vibrational analysis was performed comparing experimental vibrational spectra of the ligand and its Ln(III) complexes with theoretically predicted and with literature data from related compounds. Significant differences in the IR and Raman spectra of the complexes were observed as compared to spectra of the ligand. The ligand and the complexes were tested for cytotoxic activities on the chronic myeloid leukemia derived K-562, overexpressing the BCR-ABL fusion protein and the non-Hodgkin lymphoma derived DOHH-2, characterized by an overexpression of the antiapoptotic protein bcl-2 cell lines. The results indicate that the tested compounds exerted considerable cytotoxic activity upon the evaluated cell lines in a concentration dependent manner; we constructed dose-response curves and calculated corresponding IC50 values. The lanthanide complexes exhibited potent cytotoxic activity, even more than cisplatin towards K-562 and DOHH-2 cell lines. In order to elucidate some of the mechanistic aspects of the observed cytotoxic effects, we evaluated whether the established cytotoxicity of the most active complex La(H2pdc) is related to its capacity to induce cell death through apoptosis.